JP Morgan analyst Anupam Rama upgrades Solid Biosciences (NASDAQ:SLDB) from Underweight to Neutral.
Wells Fargo Initiates Coverage On Veeva Sys with Equal-Weight Rating, Announces Price Target of $180
Wells Fargo analyst Stan Berenshteyn initiates coverage on Veeva Sys (NYSE:VEEV) with a Equal-Weight rating and announces Price Target of $180.